CHICAGO--(BUSINESS WIRE)--Fitch Ratings has upgraded CFR Pharmaceuticals' (CFR) Issuer Default Ratings and its senior unsecured ratings and removed them from Rating Watch Positive. Fitch has also affirmed the ratings of the No. 730 and 731 bond programs, and downgraded CFR's National Equity Rating from Primera Clase Nivel 3(cl) to Primera Clase Nivel 4(cl) due to the substantial reduction in the outstanding float of the company's shares after Abbott's takeover. A full list of rating actions fol
| < Prev | Next > |
|---|
